ERBB2 and ovarian carcinoma: This analysis shows two dominant clusters of disease subtypes, with one cluster containing ER+/HER2− high proliferation and ER+/HER2− low proliferation breast cancer molecular subtypes, and the second cluster containing ovarian cancer molecular subtypes and the ER−/HER2− and HER2+ breast cancer molecular subtypes.